Company / Operating Income
TEVA PHARMACEUTICAL INDUSTRIES LTD Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$2.2B
FY2025
5-year range
-$2.2B / $2.2B
FY2021-FY2025
Trend
+811.9%
vs FY2024
Sector context
#7 of 204
Health Care
What the data says
Operating Income changed +812% YoY in FY2025, a notable deviation from the 9-year average annual change of -86%.
Based on SEC 10-K filings.
$2.2B in FY2025. Top quartile in the Health Care sector.
Improved from $433M to $2.2B over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 204This company $2.2B Sector average $107.8M
▼
+1901.8% above sector average
Key checks
Key Insights
- In FY2025, operating income increased 811.9% year-over-year.
- Ranks #7 out of 204 companies in the Health Care sector.
- Lowest operating income in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.2B | +811.9% |
| FY2024 | -$303.0M | -170.0% |
| FY2023 | $433.0M | +119.7% |
| FY2022 | -$2.2B | -228.0% |
| FY2021 | $1.7B | +148.0% |
| FY2020 | -$3.6B | -706.3% |
| FY2019 | -$443.0M | +72.9% |
| FY2018 | -$1.6B | +90.6% |
| FY2017 | -$17.5B | -911.7% |
| FY2016 | $2.2B | -35.7% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026